Genome Wide Association Analysis of the Age-at-Onset for Individuals with Alzheimer's Disease

Late-Onset Alzheimer’s Disease (LOAD) is a complex disorder with a strong genetic component. Previous studies suggest that genetic variants contribute to not just LOAD susceptibility, but to the variation of the age-at-onset (AAO). Millions of people suffer from this disease but until now there has been no way to predict the probably age at which the disease would begin to manifest. A genome-wide analysis of multitude of single nucleotide polymorphism (SNP’s) was performed on a large population of patients. The importance of identifying SNP’s that are associated with a disease allows the comparison on regions of the genome between affected and non-affected individuals. When strong associations are made they allow us to predict the likelihood of an individual being affected by the disease. In this case not only the disease but a prediction of the age at which the individual will be affected can be predicted.
Inventors: 
Jonathan HainesJohn GilbertGary BeechamMichael SliferEden MartinMargaret Pericak-Vance
Licensing manager: 
Taylor Jordan

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter